Liver steatosis in patients with rheumatoid arthritis treated with methotrexate is associated with body mass index

Table 1 Clinical characteristics

Clinical characteristics	Value
Female/male	43 (73%); 16 (27%)
Age in yr	61.52 (11.73)
Height in cm	162.02 (7.66)
Weight in kg	67.33 (10.52)
Waist circumference in cm	88.81 (10.92)
BMI in kg/m²	25.55 (3.05)
BMI < 25 score	22 (37.29%)
BMI > 25 score	37 (62.71%)
Metabolic syndrome	9 (15.25%)
Type 2 diabetes	2 (3.57%)
DAS28 score	2.36 (1.14)
Treatment duration MTX in mo	82.43 (65.08)
MTX-CD in mg	5214.5 (4031.9)
FibroScan in kPa	5.02 (2.24)
APRI in score	0.32 (0.15)
CAP in dB/m	251.33 (51.13)

Data are n (%) or mean ± SD. APRI: Aspartate aminotransferase to platelet ratio index; BMI: Body mass index; CAP: Computed attenuation parameter; DAS28: Disease Activity Score in 28 joints; MTX-CD: Methotrexate cumulative dose.